Auris Medical Holding AG (EARS) Reaches $0.27 Yearly Low; NCI Building Systems, Inc. (NCS) Covered By 8 Bullish Analysts Last Week

February 11, 2018 - By Michael Collier

The stock of Auris Medical Holding AG (NASDAQ:EARS) hit a new 52-week low and has $0.25 target or 4.00% below today’s $0.27 share price. The 7 months bearish chart indicates high risk for the $16.23 million company. The 1-year low was reported on Feb, 11 by Barchart.com. If the $0.25 price target is reached, the company will be worth $649,160 less. The stock decreased 14.42% or $0.0447 during the last trading session, reaching $0.2653. About 1.84 million shares traded or 33.11% up from the average. Auris Medical Holding AG (NASDAQ:EARS) has declined 79.78% since February 11, 2017 and is downtrending. It has underperformed by 96.48% the S&P500.

Among 10 analysts covering NCI Building Systems (NYSE:NCS), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. NCI Building Systems had 24 analyst reports since August 12, 2015 according to SRatingsIntel. The stock of NCI Building Systems, Inc. (NYSE:NCS) earned “Buy” rating by BB&T Capital on Friday, September 4. RBC Capital Markets maintained the stock with “Buy” rating in Tuesday, November 14 report. The company was maintained on Tuesday, October 17 by RBC Capital Markets. The stock of NCI Building Systems, Inc. (NYSE:NCS) earned “Sell” rating by Zacks on Wednesday, August 12. Citigroup maintained the shares of NCS in report on Thursday, January 25 with “Neutral” rating. On Monday, July 17 the stock rating was maintained by RBC Capital Markets with “Buy”. The rating was maintained by RBC Capital Markets on Friday, September 8 with “Buy”. RBC Capital Markets maintained the stock with “Sector Perform” rating in Friday, September 4 report. The firm earned “Outperform” rating on Friday, September 4 by FBR Capital. RBC Capital Markets upgraded NCI Building Systems, Inc. (NYSE:NCS) rating on Wednesday, April 26. RBC Capital Markets has “Outperform” rating and $20 target. See NCI Building Systems, Inc. (NYSE:NCS) latest ratings:




25/01/2018 Broker: Citigroup Old Rating: Neutral New Rating: Neutral Old Target: $21 New Target: $20 Maintain
08/12/2017 Broker: DA Davidson Rating: Hold New Target: $18.0
08/12/2017 Broker: RBC Capital Markets Rating: Buy New Target: $22.0 Maintain
14/11/2017 Broker: RBC Capital Markets Rating: Buy New Target: $18.0 Maintain
17/10/2017 Broker: RBC Capital Markets Rating: Buy New Target: $16.0 Maintain
08/09/2017 Broker: RBC Capital Markets Rating: Buy New Target: $16.0 Maintain
08/09/2017 Broker: Barclays Capital Rating: Overweight Old Target: $19 New Target: $16 Maintain
20/08/2017 Broker: RBC Capital Markets Rating: Buy New Target: $20.0 Maintain

Among 3 analysts covering Auris Medical Holding AG (NASDAQ:EARS), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Auris Medical Holding AG had 4 analyst reports since March 15, 2016 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, March 15 by Jefferies. The rating was maintained by Needham on Friday, August 19 with “Buy”. On Friday, June 30 the stock rating was initiated by Roth Capital with “Buy”.

Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. The company has market cap of $16.23 million. The Company’s product candidates include AM-101, which is in phase III clinical development for the treatment of acute inner ear tinnitus; and AM-111 that is in phase III clinical development for the treatment of acute inner ear hearing loss. It currently has negative earnings. The firm is also developing AM-125 for the treatment of vestibular disorders; and other pre-clinical stage products comprising AM-102 and AM-123.

NCI Building Systems, Inc., together with its subsidiaries, designs, engineers, makes, and markets metal products for the nonresidential construction industry in North America. The company has market cap of $1.08 billion. It operates through three divisions: Engineered Building Systems, Metal Components, and Metal Coil Coating. It has a 21.23 P/E ratio. The Engineered Building Systems segment offers engineered structural members and panels; and self-storage building systems under the Metallic, Mid-West Steel, A & S, All American, Mesco, Star, Ceco, Robertson, Garco, Heritage, and SteelBuilding.com brands to builders, general contractors, developers, and end users directly, as well as through private label companies.

The stock decreased 0.30% or $0.05 during the last trading session, reaching $16.35. About 585,100 shares traded. NCI Building Systems, Inc. (NYSE:NCS) has risen 17.08% since February 11, 2017 and is uptrending. It has outperformed by 0.38% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: